Cargando…
Clinical, imaging, and blood biomarkers to assess 1-year progression risk in fibrotic interstitial lung diseases—Development and validation of the honeycombing, traction bronchiectasis, and monocyte (HTM)-score
INTRODUCTION: Progression of fibrotic interstitial lung disease (ILD) leads to irreversible loss of lung function and increased mortality. Based on an institutional ILD registry, we aimed to evaluate biomarkers derived from baseline patient characteristics, computed tomography (CT), and peripheral b...
Autores principales: | Shao, Guangyu, Hawle, Patricia, Akbari, Kaveh, Horner, Andreas, Hintenberger, Rainer, Kaiser, Bernhard, Lamprecht, Bernd, Lang, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9709148/ https://www.ncbi.nlm.nih.gov/pubmed/36465895 http://dx.doi.org/10.3389/fmed.2022.1043720 |
Ejemplares similares
-
Computed tomography findings as determinants of pulmonary function tests in fibrotic interstitial lung diseases—Network-analyses and multivariate models
por: Lang, David, et al.
Publicado: (2020) -
Computed Tomography Findings as Determinants of Local and Systemic Inflammation Biomarkers in Interstitial Lung Diseases: A Retrospective Registry-Based Descriptive Study
por: Lang, David, et al.
Publicado: (2021) -
Honeycomb lung‐like structures resulting from clustering of traction bronchiectasis distally in sarcoidosis
por: Sawahata, Michiru, et al.
Publicado: (2020) -
From “traction bronchiectasis” to honeycombing in idiopathic pulmonary fibrosis: A spectrum of bronchiolar remodeling also in radiology?
por: Piciucchi, Sara, et al.
Publicado: (2016) -
Traction bronchiectasis: is it as benign as we think?
por: Bekki, Amina, et al.
Publicado: (2022)